Parabo.Drugs - Press Release

Subscribe to GoodReturns

Parabolic Drugs Ltd has informed BSE vide its letter dated April 18, 2011 regarding a Press Release with respect to Certificate of Suitability (COS) granted to the Company in respect of its one of key molecule namely "Cefixime".

Read more about: parabolic drugs ltd
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'